Yoga for Patients With Epilepsy

This study is currently recruiting participants.

Verified by Beth Israel Deaconess Medical Center, December 2007

Sponsored by:	Beth Israel Deaconess Medical Center
Information provided by:	Beth Israel Deaconess Medical Center
ClinicalTrials.gov Identifier:	NCT00179452

Purpose

To establish the safety and feasibility of having patients with epilepsy perform yoga.

Condition	Intervention
Epilepsy	Behavioral: Yoga

Genetics Home Reference related topics: pyridoxal 5'-phosphate-dependent epilepsy

MedlinePlus related topics: Epilepsy

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety Study
Official Title:	Is Yoga Safe for Patients With Epilepsy?

Further study details as provided by Beth Israel Deaconess Medical Center:

Primary Outcome Measures:

Improvement in quality of life assessments.
Improvement in mood.

Secondary Outcome Measures:

Improvement in seizure control.

Estimated Enrollment:	20
Study Start Date:	October 2003
Estimated Study Completion Date:	October 2004

Detailed Description:

Subjects will keep logs of seizure frequency prior to, during, and following training in a yoga regimen. Instruction in the yoga regimen will occur at BIDMC, and home practice following classroom instruction will occur as part of the study. Side effects, changes in seizure frequency, and quality of life assessments will be performed.

Eligibility

Ages Eligible for Study:	18 Years to 64 Years
Genders Eligible for Study:	Female
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Must be able to give full informed consent.
Must have one or more of the following seizure types: simple partial, complex partial, or secondarily generalized.
Age 18-64.
Must have 4-20 during the baseline phase.
Must have medical clearance from their primary care giver sufficient to allow for participation in yoga exercises.
Must be stable enough to allow for all anticonvulsant levels to remain constant for the duration of the study.

Exclusion Criteria:

Having primary generalized epilepsy or atonic seizures.
Having a history of status epilepticus in the past two years.
Any medical problem that would preclude participation in a yoga class.
Nonepileptic or psychogenic seizures.
Pregnancy.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00179452

Contacts

Contact: Kaarkuzhali Krishnamurthy, MD	617-667-5387	bkrishna@bidmc.harvard.edu
Contact: Robyn Stiles	617-667-5387	rstiles@bidmc.harvard.edu

Locations

United States, Massachusetts
Beth Israel Deaconess Medical Center	Recruiting
Boston, Massachusetts, United States, 02215
Contact: Kaarkuzhali B Krishanmurthy, MD 617-667-4088 bkrishna@bidmc.harvard.edu
Contact: Robyn Stiles 617-667-5387 rstiles@bidmc.harvard.edu
Sub-Investigator: Jennifer Johnston
Sub-Investigator: Ann Wohlhueter
Sub-Investigator: Jeff Dusek, PhD

Sponsors and Collaborators

Beth Israel Deaconess Medical Center

Investigators

Principal Investigator:

Kaarkuzhali Krishanmurthy, MD

Beth Israel Deaconess Medical Center

More Information

Study ID Numbers:	2003P-000337
Study First Received:	September 13, 2005
Last Updated:	December 27, 2007
ClinicalTrials.gov Identifier:	NCT00179452
Health Authority:	United States: Institutional Review Board

Keywords provided by Beth Israel Deaconess Medical Center:

epilepsy, yoga

Study placed in the following topic categories:

Epilepsy
Central Nervous System Diseases
Brain Diseases

Additional relevant MeSH terms:

Nervous System Diseases

ClinicalTrials.gov processed this record on January 14, 2009